{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Methscopolamine Bromide is an oral prescription tablet used as an anticholinergic medication to help relieve symptoms of gastrointestinal disorders, such as stomach spasms and excessive acid production. Available in 2.5 mg and 5 mg strengths, it's manufactured by i3 Pharmaceuticals, LLC under application ANDA216786. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Methscopolamine bromide \u2014 ANDA 040642 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040642", "mediaType": "text/html", "title": "Methscopolamine bromide"}], "identifier": "ANDA040642", "issued": "2016-09-16", "keyword": ["public-health", "medications", "pharmaceuticals", "drug-information", "fda"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Methscopolamine bromide"}